Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy

New England Journal of Medicine

Volumn 316, Issue 6, 1987, Pages 297-303

  Edelson, Richard ^a,b,c,d,e   Berger, Carole ^a,b,c,d,e   Gasparro, Francis ^a,b,c,d,e   Jegasothy, Brian ^a,b,c,d,e   Heald, Peter ^a,b,c,d,e   Wintroub, Bruce ^a,b,c,d,e   Vonderheid, Eric ^a,b,c,d,e   Knobler, Robert ^a,b,c,d,e   Wolff, Klaus ^a,b,c,d,e   Plewig, Gerhard ^a,b,c,d,e   McKiernan, Glynis ^a,b,c,d,e   Christiansen, Inger ^a,b,c,d,e   Oster, Martin ^a,b,c,d,e   Honigsmann, Hubert ^a,b,c,d,e   Wilford, Hubert ^a,b,c,d,e   Kokoschka, Eva ^a,b,c,d,e   Rehle, Thomas ^a,b,c,d,e   Perez, Maritza ^a,b,c,d,e   Stingl, George ^a,b,c,d,e   Laroche, Liliane ^a,b,c,d,e  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TEMPLE UNIVERSITY   (United States)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; BLOOD EXTRACORPOREAL RADIATION; CARDIOVASCULAR SYSTEM; CELL VIABILITY; CLINICAL ARTICLE; DRUG ADMINISTRATION; DRUG EFFICACY; DRUG THERAPY; ERYTHEMA; EXFOLIATIVE ERYTHRODERMA; EXTRACORPOREAL CIRCULATION; FEVER; HUMAN; HYPOTENSION; INTOXICATION; LIVER TOXICITY; LYMPHATIC SYSTEM; LYMPHOCYTE; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR SYSTEM; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PUVA; SKIN LYMPHOMA; SKIN TOXICITY; T CELL LYMPHOMA; THERAPY; TREATMENT; ULTRAVIOLET A RADIATION;

ADMINISTRATION, ORAL; ADULT; AGED; CLINICAL TRIALS; FEMALE; HUMANS; LYMPHOMA; MALE; METHOXSALEN; MIDDLE AGED; PUVA THERAPY; SKIN NEOPLASMS; T-LYMPHOCYTES;

EID: 0023145057     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198702053160603     Document Type: Article

References (34)

1. Cohen IR. Autoimmunity: physiologic and pernicious. Adv Intern Med 1984; 29: 147–65.
2. Ben-Nun A, Wekerle H, Cohen IR. Vaccination against autoimmune encephalomyelitis with T lymphocyte line cells reactive against myelin basic protein. Nature 1981; 292: 60–1.
3. Holoshitz J, Naparstek Y, Ben-Nun A, Cohen IR. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 1983; 219: 56–8.
4. Scott BR, Pathak MA, Mohn GR. Molecular and genetic basis of furocoumarin reactions. Mutat Res 1976; 39: 29–74.
5. Song P-S, Tapley KJ Jr. Photochemistry and photobiology of psoralens. Photochem Photobiol 1979; 29: 1177–97.
6. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 1974; 291: 1207–11.
7. Melski JW, Tanenbaum L, Parrish JA, et al. Oral methoxsalen photochemistry for the treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol 1977; 68: 328–35.
8. Gilchrest BA, Parrish JA, Tanenbaum L, Haynes HA, Fitzpatrick TB. Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer 1976; 38: 683–9.
9. Hönigsmann H, Brenner W, Rauschmeier W, Konrad K, Wolff K. Photochemotherapy for cutaneous T cell lymphoma. J Am Acad Dermatol 1984; 10: 238–45.
10. Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL. Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 1984; 310: 1156–61.
11. Knobler RM, Edelson RL. Cutaneous T cell lymphoma. Med Clin North Am 1986; 70: 109–38.
12. Lamberg SI. Green SB, Byar DP, et al. Clinical staging for cutaneous T-cell lymphoma. Ann Intern Med 1984; 100: 187–92.
13. Berger CL, Morrison S, Chu A, et al. Diagnosis of cutaneous T cell lymphoma by use of monoclonal antibodies reactive with tumor-associated antigens. J Clin Invest 1982; 70: 1205–15.
14. Vonderheid EC, Sobel EL, Nowell PC, Finan JB, Helfrich MK, Whipple S. Diagnostic and prognostic significance of Sézary cells in peripheral blood smears from patients with cutaneous T cell lymphoma. Blood 1985; 66: 358–66.
15. Peiper SC, Berard CW. Classification and morphology of non-Hodgkin's lymphoma. In: Murphy GF. Mihm MC, eds. Lymphoproliferative disorders of the skin. Boston: Butterworths, 1986:3–30.
16. Bertness V, Kirsch I, Hollis G, Johnson B, Bunn PA Jr. T cell gene rearrangements as clinical markers of human T cell lymphomas. N Engl J Med 1985; 313: 534–8.
17. Weiss LM, Hu E, Wood GS, et al. Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Engl J Med 1985; 313: 539–44.
18. Berger CL, Benn P, Chow J, et al. Clonal rearrangement of the T cell receptor gene and dual genotypes in cutaneous T cell lymphoma. Clin Res 1986; 34: 737A. abstract.
19. Edelson RL, Berger CL, Raafat J, Warburton D. Karyotype studies of cutaneous T cell lymphoma: evidence for clonal origin. J Invest Dermatol 1979; 73: 548–50.
20. Nowell PC, Finan JB, Vonderheid EC. Clonal characteristics of cutaneous T cell lymphomas: cytogenetic evidence from blood, lymph nodes, and skin. J Invest Dermatol 1982; 78: 69–75.
21. Eisinger M. Cultivation of normal human epidermal keratinocytes and melanocytes. In: Skerrow D. Skerrow CJ, eds. Methods in skin research. New York: John Wiley, 1985:195.
22. Berger CL, Cantor C, Welsh J, et al. Comparison of synthetic psoralen derivatives and 8-MOP in the inhibition of lymphocyte proliferation. Ann NY Acad Sci 1985; 453: 80–90.
23. Puglisi CV, de Silva AJ, Meyer JC. Determination of 8-methoxypsoralen, a photoactive compound, in blood by high pressure liquid chromatography. Anal Lett 1977; 10: 39–50.
24. Santella RM, Dharmaraja N, Gasparro FP, Edelson RL. Monoclonal antibodies to DNA modified by 8-methoxypsoralen and ultraviolet A light. Nucleic Acids Res 1985; 13: 2533–44.
25. Gasparro FP, Chan G, Edelson RL. Phototherapy and photopharmacology. Yale J Biol Med 1985; 58: 519–34.
26. Lutzner M. Edelson R. Schein P. Kirkpatrick C. Green I. Ahmed A. Cutaneous T-cell lymphoma: Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med 1975; 83: 534–52.
27. Rosenberg SA, Lotze MT, Muul LM, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313: 1485–92.
28. Morison WL, Wimberly J, Parrish JA, Bloch KJ. Abnormal lymphocyte function following long-term PUVA therapy for psoriasis. Br J Dermatol 1983; 108: 445–50.
29. Edelson RL, Facktor M, Andrews A, Lutzner M, Schein P. Successful management of the Sézary syndrome: mobilization and removal of extravascular neoplastic T cells by leukapheresis. N Engl J Med 1974; 291: 293–4.
30. Pineda AA, Winkelmann RK. Leukapheresis in the treatment of Sézary syndrome. J Am Acad Dermatol 1981; 5: 544–9.
31. Perez M, Gapas Y, O'Neil D. Edelson R, Berger C, Inhibition of murine autoimmune disease by reinfusion of syngeneic lymphocytes inactivated with psoralen and ultraviolet A light. Clin Res 1986; 34: 774A. abstract.
32. Yemul S. Berger C, Estabrook A, Edelson R, Bayley H. Delivery of phototoxic drugs to selected cells. Ann NY Acad Sci 1985; 446: 403–14.
33. Oseroff AR, Wimberly J, Lee C, Alvarez V, Parrish JA. Photosensitized destruction of normal and leukemic T cells using monoclonal antibody (MAb)-directed hematoporphyrin. J Invest Dermatol 1985; 84: 335A. abstract.
34. Gasparro FP, Knobler RM, Yemul SS, Bisaccia E, Edelson RL. Receptor-mediated photo-cytotoxieity: synthesis of a photoactivatable psoralen derivative conjugated to insulin. Biochem Biophys Res Commun 1986; 141: 502–9.